Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2026-01-05 @ 10:01 PM
Study NCT ID:
NCT01608594
Status:
COMPLETED
Last Update Posted:
2018-08-28
First Post:
2012-05-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma
Sponsor:
Diwakar Davar
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-21
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-27
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-26
First Submit QC Date:
None
Study First Post Date:
2012-05-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-24
Last Update Post Date:
2018-08-28
Last Update Post Date Type:
ACTUAL